CNBC: Black health leaders try to build trust in the COVID-19 vaccine among African Americans
Louito Edje, MD, wants to inspire confidence in COVID-19 vaccine
African-American health professionals and community health groups across the country have already begun to do outreach in Black communities hit hard by the coronavirus.
Seven out of 10 African Americans know someone who’s been hospitalized or died from COVID-19, according to a Pew Research poll conducted last month. Yet vaccine skepticism runs high. Only 42% of Blacks surveyed say they plan to be vaccinated, compared with more than 60% for Americans overall.
The vaccine is almost here, but we can't get to a new normal if people don't take the shot. According to a Pew survey, only about 60% of Americans say they'll get the vaccine. However, only 42% of black adults say they'll get it.
— The News with Shepard Smith (@thenewsoncnbc) December 11, 2020
CNBC's @berthacoombs has the story. pic.twitter.com/WvdTOyUPIg
Louito Edje, MD, associate dean of graduate medical education at the UC College of Medicine and UC Medical Center, enrolled in the Phase 3 clinical trial for SARS-CoV-2 vaccine after three of her relatives died from the coronavirus. UC is one of approximately 90 sites in the country to host a trial for the mRNA-1273 vaccine developed by the National Institute of Allergy and Infectious Diseases scientists and collaborators at biotechnology company Moderna.
Edje holds a master's of health professions education and is a fellow of the American Academy of Family Physicians. She wanted to set an example and inspire confidence in her patients to get vaccinated. Edje shared her story with CNBC as part of a segment including interviews from health professionals across the country and community groups promoting vaccination against COVID-19. “I felt that I might be able to have an impact that has some credibility, for the patients that I take care of every day who look just like me,” Edje told CNBC.
Learn more about Dr. Edje online.
Featured image with Louito Edje, MD, in front of the UC College of Medicine by Colleen Kelley/University of Cincinnati.
Impact Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
College of Medicine celebrates 100% match rate for Class of 2026
March 23, 2026
From local hospitals to the Mayo Clinic, the UC College of Medicine Class of 2026 achieved a 100% match rate for their residency training destinations.
Struggling with daily HIV meds?
March 23, 2026
For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.
Extended-release buprenorphine viable, safe during pregnancy
March 23, 2026
MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.